A comparison of letrozole to gonadotropins for ovulation induction, in subjects who failed to conceive with clomiphene citrate

Fertility and Sterility

Volumn 88, Issue 4, 2007, Pages 879-885

  Quintero, Rudolfo B ^a   Urban, Renata ^a   Lathi, Ruth B ^a   Westphal, Lynn M ^a   Dahan, Michael H ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

aromatase inhibitor; clomid; clomiphene citrate; controlled ovarian hyperstimulation; gonadotropin; Letrozole

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CLOMIFENE CITRATE; GONADOTROPIN DERIVATIVE; HUMAN MENOPAUSAL GONADOTROPIN; LETROZOLE; NOVAREL; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; UROFOLLITROPIN;

ADULT; ARTICLE; COHORT ANALYSIS; CONCEPTION; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; FEMALE INFERTILITY; FETUS HEART RATE; HUMAN; LIFE TABLE; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION; TRANSVAGINAL ECHOGRAPHY; TREATMENT RESPONSE;

ADULT; AROMATASE INHIBITORS; CLOMIPHENE; COHORT STUDIES; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; NITRILES; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; RETROSPECTIVE STUDIES; TRIAZOLES;

EID: 34848881046     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.11.166     Document Type: Article

References (20)

1. Mitwally M.F., and Casper R.F. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 75 (2001) 305-309
2. Fisher S.A., Reid R.L., Van Vugt D.A., and Casper R.F. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil Steril 78 (2002) 280-285
3. Karaer O., Vatansever H.S., Oruc S., Ozbilgin K., Cilaker S., and Koyuncu M.F. The aromatase inhibitor anastrozole is associated with favorable embryo development and implantation markers in mice ovarian stimulation cycles. Fertil Steril 83 (2005) 1797-1806
4. Mitwally M.F., Casper R.F., and Diamond M.P. The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment. Reprod Biol Endocrinol 3 (2005) 54
5. Garcia-Velasco J.A., Moreno L., Pachecho A., Guillen A., Duque L., Requena A., et al. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril 84 (2005) 82-87
6. Sohrabvand F., Ansari S., and Bagheri M. Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Hum Reprod 21 (2006) 1432-1435
7. Al-Fadhli R., Sylvestre C., Buckett W., Tan S.L., and Tulandi T. A randomized trial of superovulation with two different doses of letrozole. Fertil Steril 85 (2006) 161-164
8. Mitwally M.F., and Casper R.F. Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum Reprod 18 (2003) 1588-1597
9. Ryan G.L., Moss V., Davis W.A., Sparks A.E., Dokras A., and Van Voorhis B.J. Oral ovulation induction agents combined with low-dose gonadotropin injections and intrauterine insemination: cost and clinical effectiveness. J Reprod Med 50 (2005) 943-950
10. Jacobs H.S., and Agrawal R. Complications of ovarian stimulation. Baillieres Clin Obstet Gynaecol 12 (1998) 565-579
11. Speroff L., and Fritz M.A. Induction of ovulation in clinical gynecologic endocrinology and infertility. 7th ed. (2005), Lippincott, Williams & Wilkins, Philadelphia
12. Mitwally M.F., Biljan M.M., and Casper R.F. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol 192 (2005) 381-386
13. Fadhli R., Sylvestre C., Buckett W., Tan S.L., and Tulandi T. A randomized trial of superovulation with two different doses of letrozole. Fertil Steril 85 (2006) 161-164
14. Atay V., Cam C., Muhcu M., Cam M., and Karateke A. Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. J Int Med Res 34 (2006) 73-76
15. Elnashar A., Fouad H., Eldosoky M., and Saeid N. Letrozole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle-stimulating hormone ratio. Fertil Steril 85 (2006) 511-513
16. Tulandi T., Martin J., Al-Fadhli R., Kabli N., Forman R., Hitkari J., et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 85 (2006) 1761-1765
17. Holzer H., Casper R., and Tulandi T. A new era in ovulation induction. Fertil Steril 85 (2006) 277-284
18. Speroff L., and Fritz M.A. Recurrent early pregnancy loss in clinical gynecologic endocrinology and infertility. 7th ed. (2005), Lippincott, Williams & Wilkins, Philadelphia
19. Henderson J., Hockley C., Petrou S., Goldacre M., and Davidson L. Economic implications of multiple births: inpatient hospital costs in the first 5 years of life. Arch Dis Child Fetal Neonatal Ed 89 (2004) 542-545
20. Lenton E.A. Stimulated intrauterine insemination: efficient, cost-effective, safe?. Hum Fertil (Camb) 7 (2004) 253-265